Gift establishes the Sherron Berg Early Detection Pancreatic Cancer Program at Piedmont Oncology

Atlanta, Ga. (March 10, 2026) – Piedmont Oncology announced a significant philanthropic gift to support its Early Detection Pancreatic Cancer Clinic (EDC) and to establish an endowed medical director position for the clinic. This major investment will advance this clinic’s clinical operations and associated research for years to come.

In recognition of this transformational investment, the program will now be known as the Sherron Berg Early Detection Pancreatic Cancer Program and a related clinical space is also publicly recognized as the Sherron Berg Surgical Oncology and Hepato-Pancreato Biliary (HPB) Surgery Clinic. While this gift represents a pivotal milestone, Piedmont Oncology leadership emphasizes that the need and opportunity for philanthropic partnership continue.

“I am truly excited by the incredible impact this gift will have on our work going forward,” said Andrew Page, MD, who has been named Sherron Berg Endowed Medical Director. “Sherron is an inspiration to me and all who know her, and I am humbled and honored to proudly have her name on my coat as we continue this fight to find earlier detection and cures for pancreatic cancer."

Berg was diagnosed with pancreatic cancer in 2023, which was discovered at Stage 2. Berg underwent a Whipple surgery performed by Dr. Page, the EDC founder, at Piedmont that improved her chances of curative treatment. Berg receives ongoing care at Piedmont and recently shared her story and the importance of early detection in pancreatic cancer at Piedmont Oncology’s Luminaria fundraising gala.

Berg saw her name unveiled in the clinic space during a recent special celebration, where she was surrounded by friends and family who traveled from across the country. The tribute reflects the Bergs’ shared vision with Piedmont Oncology to bring more cures to Georgians through early detection and research.

The EDC’s endowed medical director is also named through the Bergs’ generosity. In addition to his new title, Dr. Page will continue to lead the clinic’s clinical strategy, research initiatives and national collaborations. He also serves as director of Surgical Oncology and HPB Surgery for Piedmont.

With help from the Bergs’ friends and family, the EDC opened in November 2025 at Piedmont Atlanta Hospital. The first of its kind in Georgia, the EDC provides comprehensive risk assessment, improves awareness of pancreatic cancer, enhances access for referring clinicians and patients, and accelerates research collaboration. Philanthropic support has been essential to the clinic’s establishment and advancement. The newly created endowment will provide consistent, long-term funding to ensure the program’s growth and sustainability well into the future.

“Launching this clinic is only the beginning,” said Whitaker Endowed Chief of Piedmont Oncology Walter (Wally) Curran, MD. “Expanding its reach and the clinic’s research programs, and ultimately changing the trajectory of pancreatic cancer in Georgia will require ongoing community support.”

Pancreatic cancer remains one of the most aggressive and treatment-resistant cancers. According to the American Cancer Society, the five-year survival rate for all cases is 13%. Despite pancreatic cancer not being a common cancer, it is the fourth-leading cause of cancer mortality in the United States. In Georgia, incidence rates exceed the national average and disproportionately affect African American communities. Early detection remains one of the most promising strategies to improve survival.

Those interested in supporting the Sherron Berg Early Detection Pancreatic Cancer Program may do so at give.piedmont.org/pancreas.

Patients may access the clinic through physician referral or self-referral.